Z-1484-2026 Class II Ongoing

Recalled by Siemens Healthcare Diagnostics, Inc. — Tarrytown, NY

FDA device recall Z-1484-2026 was initiated by Siemens Healthcare Diagnostics, Inc. on Jan 20, 2026 and is designated Class II. Reason for recall: Falsely depressed UAlb patient results may occur. Affected samples with any urine albumin concentration above the UAlb measuring interval >40.0 mg/dL may report values between 6.2 mg/dL and 40.0… The recall status is ongoing. Affected quantity: 4,885 units.

Recall details

Product Type
Devices
Report Date
Mar 11, 2026
Initiation Date
Jan 20, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
4,885 units

Product description

Atellica CH Urine Albumin (UAlb). Material Number: 11537225

Reason for recall

Falsely depressed UAlb patient results may occur. Affected samples with any urine albumin concentration above the UAlb measuring interval >40.0 mg/dL may report values between 6.2 mg/dL and 40.0 mg/dL.

Distribution pattern

Worldwide distribution - US Nationwide and the countries of Australia, Austria, Belgium, Brazil, Canada, Chile, Curacao,¿St¿Eus, Czech¿Republic, Denmark, Finland, France, Germany, Greece, Hong Kong, Ireland, Israel, Italy, Korea, Latvia, Malaysia, Netherlands, New Zealand, Norway, Portugal, Romania, Singapore, Slovakia, South Africa, Spain, Sweden, Switzerland, United¿Kingdom.

Code information

Material Number: 11537225. UDI-DI: 00630414611099. Lot Numbers: All lot numbers.

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1484-2026
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1484-2026. Report a data issue: hello@regdatalab.com.